Nebenwirkungen · NovoRapid
NovoRapid 100 units/ml solution for injection in vial NovoRapid Penfill 100 units/ml solution for injection in cartridge NovoRapid FlexPen 100 units/ml solution for injection in pre-filled pen NovoRapid InnoLet 100 units/ml solution for injection in pre-filled pen NovoRapid FlexTouch 100 units/ml solution for injection in pre-filled pen NovoRapid PumpCart 100 units/ml solution for injection in cartridge · Abschnitt 4.8 · PDF-Seite 9
HOS-090227 · Präparat HOS-084033
Anaphylactic reactions: The occurrence of generalised hypersensitivity reactions (including generalised skin rash, itching, sweating, gastrointestinal upset, angioneurotic oedema, difficulties in breathing, palpitation and reduction in blood pressure) is very rare but can potentially be life threatening.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-05-28T02:00:00Z · SHA-256 596b72a285a1a6a53ef22a3d8e8f5b78afcad8d6266d30dcb5e7e2429eede7f2 · Passage bcad98274037d45ac3f5253abd1c54e534527064e6cf5793009f8a1ea2518ab0 · Zeichen 2390–2695 im Abschnitt